Frontlight ResearchEarly access
Trial site
Vandœuvre-lès-Nancy
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia5 trials
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- High blood pressure1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Myelodysplastic syndromes1 trial
- Pancreatic cancer1 trial
- Pulmonary arterial hypertension1 trial
- Sarcoma1 trial
- and 2 more
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Completed2 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals10 trials
Running trials
Recruiting
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- High blood pressure1 recruiting
- Lung cancer1 recruiting
- Pancreatic cancer1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Completed
Terminated
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 12 Nov 2026